Pandemic Taking Its Toll On The US FDA’s Non-Pandemic Work, Alkermes CEO Says

 
• By Derrick Gingery
  
Richard Pops says the advisory committee system is broken and problems are made worse with virtual meetings.
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from US FDA Performance Tracker

More from Regulatory Trackers